Browsing: Pharma

Big drug companies are aligning with President Donald Trump’s “most-favored-nation” (MFN) drug pricing policy, but…

Less than two weeks after Pfizer signed a deal with a Chinese pharmaceutical company to…

Servier, run by a nonprofit group, continues to make money with its IDH-mutant glioma treatment…

Kyowa Kirin has decided to halt all clinical development of its OX40 drug following the…

The design of modern research and development labs may need to be rethought. Artificial intelligence…

Outstanding trial results for the combination of Tekvayli and Darzalex Faspro in previously treated relapsed…

Since discontinuing two branded versions of its asthma inhaler Flovent in early 2024, GSK is…

Germany’s Merck KGaA, which achieved solid sales growth in a difficult 2025, could find itself…

Galderma significantly raised its annual peak sales forecast for Nemulvio (nemolizumab) to more than $4…

Leo Pharma has decided to launch the JAK inhibitor cream Anzupgo. The Danish pharmaceutical company,…